Ergots
Ergotamine is effective for acute migraine but should be reserved as a third-line option only after failure of triptans combined with NSAIDs or acetaminophen, due to its higher risk of medication-overuse headache, ergot poisoning, and inferior tolerability compared to preferred treatments - Medical Advisory Board

image by: HWN
HWN Suggests
Revisiting the role of ergots in the treatment of migraine and headache
The harmful side effects of the ergots described by early civilizations have been overcome with efficacious treatment for headaches including migraine, cluster, and chronic daily headache. Use of ergots contributed to initial theories of migraine pathogenesis and provided the substrate for development of the triptans. Triptans are very efficacious for many migraineurs, and since their widespread use, use of ergots has significantly declined. Unfortunately, there remain many migraineurs who benefit little from triptans, yet respond very well to ergots. Discoveries in migraine pathophysiology have given us better understanding of the complex processes involved, although there remain many unknown…Featured
From Poisoning to Pharmacy: A Tale of Two Ergots
In 1868, ergot was adapted to treat another medical condition: migraine headaches. The active ingredient for this treatment, ergotamine, was purified in 1918 and its use in this context remains widespread. In the U.S. and Europe, ergotamine is a drug of choice for patients with infrequent or long-duration headaches and who will comply with the dosing regimen and restrictions. This is particularly important since most reported cases of ergotism are now sporadic and a result of ergot alkaloid treatments. If not properly administered, extended ergot-based therapies can lead to ergot alkaloid accumulation and gangrenous ergotism (purified alkaloids don't cause convulsive ergotism).
Is ergotamine effective for treating migraine headaches?
The 2025 American College of Physicians guidelines establish a clear hierarchy where ergotamine (specifically dihydroergotamine) is considered only after patients fail combination therapy of a triptan plus NSAID or acetaminophen. This represents a significant demotion from its historical role as the standard abortive migraine therapy.
Articles of Interest
DHE (dihydroergotamine) and ergotamine
Ergots are some of the oldest migraine-specific drugs. They are used to treat moderate to severe migraine when they start (acute treatment). In some cases, ergots are used to treat persistent migraines that are hard to treat or fail to respond to standard or aggressive treatment (refractory migraine). Because ergots can cause serious side effects, they are usually a second- or third-line treatment. Ergots are often reserved as an option for people for whom triptans have failed or have hard-to-treat migraine. Ergots come in several forms, including pills, injections, suppositories, and nasal spray.
Dihydroergotamine for migraine: Evidence for multiple modes of action: The single molecule ‘combination’ product—A narrative review
From several decades of work, pharmacological studies have shown that dihydroergotamine (DHE) has affinity for many more receptors than just serotonergic (5-HT)1B and 5-HT1D; stimulation of which is generally considered to be the mechanism of action of triptans in the treatment of migraine.
Ergot Alkaloids - Anti-Migraine Drugs
Ergot is produced by a fungus, Claviceps purpurea, which infests certain types of grain, especially rye. The spores of the fungus are carried by insects or wind to young rye where they germinate into hyphae (filaments). The hyphae penetrate deep into the grain and harden into a purplish structure called sclerotium, which elaborates a number of ergot alkaloids, (videinfra). During wet seasons, C. purpura can infest wheat, barley,rye (most common), oats, wheatgrass, quackgrass, smooth bromegrass, wild rye and bluegrasses.
Ergot Alkaloids in the Acute Treatment of Migraines
Ergotamine and dihydroergotamine have been in use for a very long time and, therefore, they did not undergo a controlled clinical trial program that would be expected of a new drug today. Not surprisingly, the number of good clinical trials incorporating such a widely used drugs as ergotamine is not great.
Ergot of rye—the first specific for migraine
Over the past decade the various triptan derivatives have been accepted as the most effective available agents for relieving migraine attacks. Prior to that, for a period of half a century, ergotamine was the only ‘specific’ available for this purpose. In 1918, Stoll had isolated it from the various alkaloids present in extracts of the sclerotia of the fungus Claviceps purpurea (ergot), which grow on rye and, to a lesser extent, on other grasses. By 1925 ergotamine was beginning to be used to treat migraine attacks.
Ergot: Miracle Drug or Death Sentence?
Ergot alkaloids are still a valuable resource for modern medicine. The broad spectrum of pharmacological activities includes modulation of blood pressure, migraine prevention, and helps provoke dopamine activity. This modern drug is even used for inducing contractions, preventing postpartum hemorrhaging and is a antipsychosis drug.
Has Ergot Altered Events in World History?
Ergot has been known for millennia, but was not recognized as causing health issues until about 200 years ago. For example, an Assyrian tablet dating to 600 BC mentions “noxious pustules” on grain seeds.
Medicine: Ergot Controversy
Ergot is rotted rye. A fungus grows on the rye head and eats away the grains. What is left is a collection of hard bodies, each shaped like a cock’s spur. Hence the name ergot, from French argot (spur). Good, dry ergot is of inestimable value in obstetrics. Its extract contracts the uterus and arteries, stops hemorrhages, raises blood pressure. Good ergot saves the lives and bolsters the health of hundreds of thousands of women annually. But bad ergot may contain poisons which cause abscesses and kill. U. S. pharmacists get their raw ergot from Spain, Portugal, Poland and Russia.
Risk of stroke, gangrene from ergot drug interactions
Unlike triptan medications, which have a more selective affinity for serotonin 5-HT1 receptors, ergotamine and dihydroergotamine are nonselective 5-HT1 agonists. They also have affinities for dopamine and noradrenaline receptors. Common adverse effects of ergotamine and dihydroergotamine are nausea, vomiting, abdominal pain, diarrhea, peripheral paresthesias, swollen fingers, generalized weakness, and peripheral and coronary vasoconstriction.
The early use of ergotamine in migraine. Edward Woakes' report of 1868, its theoretical and practical background and its international reception
Contrary to Woakes' theory, in the early 20th century ergot was used for migraine because of its well-documented adrenolytic properties, as migraine was by then again believed to be a sympathotonic and vasospastic condition.
The Fascinating History of Triptans
Ergotamine, discovered in 1918, was initially used to treat migraine by constricting blood vessels, a sensible approach given the theory that migraine was caused by blood vessel dilation. However, ergotamine had severe side effects, including high blood pressure and the risk of gangrene. This led researchers to seek a milder alternative. The quest for a safer migraine treatment culminated in the 1970s with the development of sumatriptan by Glaxo, which was marketed in the USA in 1993. Sumatriptan revolutionized migraine treatment with its effectiveness and shifted the perception of migraine from a psychiatric issue to a neurological condition.
What is the mechanism of Ergotamine Tartrate?
The primary mechanism by which ergotamine tartrate exerts its effects is through its action on serotonin (5-HT) receptors. Serotonin is a key neurotransmitter involved in the regulation of mood, appetite, and the constriction of blood vessels. Specifically, ergotamine tartrate acts as an agonist at the 5-HT1B and 5-HT1D receptors. Activation of these receptors leads to vasoconstriction, which is the narrowing of blood vessels. This is particularly important in the context of migraines, as it is believed that the dilation of intracranial blood vessels contributes to the throbbing pain associated with migraine headaches.

